[go: up one dir, main page]

WO2016007871A3 - Motifs immunitaires dans des produits issus d'animaux domestiques - Google Patents

Motifs immunitaires dans des produits issus d'animaux domestiques Download PDF

Info

Publication number
WO2016007871A3
WO2016007871A3 PCT/US2015/039970 US2015039970W WO2016007871A3 WO 2016007871 A3 WO2016007871 A3 WO 2016007871A3 US 2015039970 W US2015039970 W US 2015039970W WO 2016007871 A3 WO2016007871 A3 WO 2016007871A3
Authority
WO
WIPO (PCT)
Prior art keywords
immune
motifs
products
product
domestic animals
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2015/039970
Other languages
English (en)
Other versions
WO2016007871A2 (fr
Inventor
Robert D. Bremel
Jane Homan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ioGenetics LLC
Original Assignee
ioGenetics LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ioGenetics LLC filed Critical ioGenetics LLC
Priority to NZ728239A priority Critical patent/NZ728239A/en
Priority to US15/325,654 priority patent/US10799582B2/en
Priority to AU2015287622A priority patent/AU2015287622B2/en
Priority to EP15819480.3A priority patent/EP3166631B1/fr
Publication of WO2016007871A2 publication Critical patent/WO2016007871A2/fr
Publication of WO2016007871A3 publication Critical patent/WO2016007871A3/fr
Anticipated expiration legal-status Critical
Priority to AU2019200707A priority patent/AU2019200707A1/en
Priority to US17/066,959 priority patent/US20210023212A1/en
Priority to AU2021200558A priority patent/AU2021200558B2/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39508—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum from milk, i.e. lactoglobulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39583—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials not provided for elsewhere, e.g. haptens, coenzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39591—Stabilisation, fragmentation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/04—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from milk
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/12—Immunoglobulins specific features characterized by their source of isolation or production isolated from milk
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
    • C07K2317/94—Stability, e.g. half-life, pH, temperature or enzyme-resistance

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

La présente invention concerne un moyen pour préparer un produit à partir de lait, de sang ou d'œufs d'animaux domestiques, qui comprend une série de motifs exposés par les cellules T similaires en termes d'identité, de répartition et de concentration à ceux observés dans les régions variables d'immunoglobulines humaines et pour préparer et appliquer le produit en tant qu'agent de modulation immunitaire pour une administration soit en tant que complément nutritionnel, soit en tant que produit pharmaceutique.
PCT/US2015/039970 2014-07-11 2015-07-10 Motifs immunitaires dans des produits issus d'animaux domestiques Ceased WO2016007871A2 (fr)

Priority Applications (7)

Application Number Priority Date Filing Date Title
NZ728239A NZ728239A (en) 2014-07-11 2015-07-10 Immune motifs in products from domestic animals
US15/325,654 US10799582B2 (en) 2014-07-11 2015-07-10 Immunoglobulin polypeptide fractions from products of domestic animals
AU2015287622A AU2015287622B2 (en) 2014-07-11 2015-07-10 Immune motifs in products from domestic animals
EP15819480.3A EP3166631B1 (fr) 2014-07-11 2015-07-10 Motifs immunitaires dans des produits issus d'animaux domestiques
AU2019200707A AU2019200707A1 (en) 2014-07-11 2019-02-01 Immune motifs in products from domestic animals
US17/066,959 US20210023212A1 (en) 2014-07-11 2020-10-09 Immune motifs in products from domestic animals
AU2021200558A AU2021200558B2 (en) 2014-07-11 2021-01-29 Immune motifs in products from domestic animals

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201462023220P 2014-07-11 2014-07-11
US62/023,220 2014-07-11
US201562138460P 2015-03-26 2015-03-26
US62/138,460 2015-03-26

Related Child Applications (2)

Application Number Title Priority Date Filing Date
US15/325,654 A-371-Of-International US10799582B2 (en) 2014-07-11 2015-07-10 Immunoglobulin polypeptide fractions from products of domestic animals
US17/066,959 Continuation US20210023212A1 (en) 2014-07-11 2020-10-09 Immune motifs in products from domestic animals

Publications (2)

Publication Number Publication Date
WO2016007871A2 WO2016007871A2 (fr) 2016-01-14
WO2016007871A3 true WO2016007871A3 (fr) 2016-03-10

Family

ID=55065098

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2015/039970 Ceased WO2016007871A2 (fr) 2014-07-11 2015-07-10 Motifs immunitaires dans des produits issus d'animaux domestiques

Country Status (5)

Country Link
US (2) US10799582B2 (fr)
EP (1) EP3166631B1 (fr)
AU (3) AU2015287622B2 (fr)
NZ (1) NZ728239A (fr)
WO (1) WO2016007871A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20210265008A1 (en) * 2018-05-10 2021-08-26 Iogenetics, Llc Immune repertoire patterns
WO2022125504A1 (fr) * 2020-12-07 2022-06-16 Iogenetics, Llc Vaccins à protéines bystander
CN113854654B (zh) * 2021-09-23 2025-08-29 百安健康复医疗（深圳）有限公司 束胸衣

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070014796A1 (en) * 1997-05-21 2007-01-18 Biovation Limited Method for the production of non-immunogenic proteins

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
EP2550529B1 (fr) 2010-03-23 2021-11-17 Iogenetics, LLC. Procédés bioinformatiques pour déterminer la liaison de peptides
EP2771349B1 (fr) 2011-09-16 2020-02-26 Iogenetics, LLC. Procédés bio-informatiques de détermination de liaisons peptidiques
JP2014011083A (ja) 2012-06-29 2014-01-20 Canon Inc 有機ｅｌ表示装置の製造方法
EP2684986B1 (fr) 2012-07-12 2016-11-02 Thomas GmbH Procédé d'oxydation électrolytique de surfaces sur des corps creux métalliques
US11069427B2 (en) 2013-06-10 2021-07-20 Iogenetics, Llc Mathematical processes for determination of peptidase cleavage

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070014796A1 (en) * 1997-05-21 2007-01-18 Biovation Limited Method for the production of non-immunogenic proteins

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
KONUSPAYEVA ET AL.: "Lactoferrin and immunoglobulin contents in camel's milk (Camelus bactrianus, Camelus dromedarius, and Hybrids) from Kazakhstan.", J DAIRY SCI., vol. 90, no. 1, 2007, pages 38 - 46, XP026955655 *
SHIN ET AL.: "Use of Egg Yolk-Derived Immunoglobulin as an Alternative to Antibiotic Treatment for Control of Helicobacter pylori Infection.", CLIN DIAGN LAB IMMUNOL., vol. 9, no. 5, 2002, pages 1061 - 1066, XP002524383, DOI: doi:10.1099/jmm.0.04978-0 *
TSABOURI ET AL.: "Cow's milk allergenicity.", ENDOCR METAB IMMUNE DISORD DRUG TARGETS, vol. 14, no. 1, March 2014 (2014-03-01), pages 16 - 26, XP055383557 *

Also Published As

Publication number Publication date
AU2019200707A1 (en) 2019-02-21
AU2015287622B2 (en) 2018-11-01
AU2021200558B2 (en) 2023-03-09
US20180221474A1 (en) 2018-08-09
WO2016007871A2 (fr) 2016-01-14
EP3166631A2 (fr) 2017-05-17
EP3166631A4 (fr) 2018-03-21
US20210023212A1 (en) 2021-01-28
AU2015287622A1 (en) 2017-02-02
AU2021200558A1 (en) 2021-03-04
NZ728239A (en) 2018-08-31
EP3166631B1 (fr) 2023-09-06
US10799582B2 (en) 2020-10-13
EP3166631C0 (fr) 2023-09-06

Similar Documents

Publication Publication Date Title
EP3897510A4 (fr) Distributeur de pilules pour médicaments, vitamines et/ou compléments alimentaires
EP4421094A3 (fr) Agents thérapeutiques ciblés et leurs utilisation
WO2016172657A3 (fr) Agents thérapeutiques de glycanes et procédés de traitement
WO2017095944A8 (fr) Procédés et compositions se rapportant à des chondrisomes provenant de produits sanguins
PH12017501342A1 (en) Glycan therapeutics and related methods thereof
Sarbatova et al. Developing a specialized meat product based on ostrich
WO2016004213A3 (fr) Hydrogels pour traiter et améliorer des cancers et potentialiser le système immunitaire et procédés pour les produire et les utiliser
EP4218823A3 (fr) Nouveaux promédicaments à base d'hormone de croissance humaine (hgh) polymère
EP3641557A4 (fr) Réduction de fumonisine dans des produits de protéine de maïs
EP3243517A4 (fr) Composition médicinale, dispositif de traitement de sang, produit cosmétique, aliment et boisson utilisant une matière de synthèse de combustion
WO2016128838A3 (fr) Compositions lipidiques
MY174991A (en) Eurycoma longifolia extract and its use in enhancing and/or stimulating immune system
PH12016501952A1 (en) Nutritional compositions directed to subjects having cow`s milk protein allergies
WO2016193924A3 (fr) Systèmes de multiples sacs et procédé pour la préparation d'hémocomposants
MX392017B (es) Conservación de vitaminas hidrosolubles.
IL270936A (en) A factor, food and drug that improve brain activity through lipopolysaccharide
WO2018097712A8 (fr) Procédé de préparation d'un produit glucidique et/ou protéique
WO2016020880A3 (fr) Anticorps de l'angiopoïétine-like 4 et procédés d'utilisation correspondants
WO2016020882A3 (fr) Anticorps de type angiopoétine 4 (angptl4) et procédés d'utilisation
WO2016007871A3 (fr) Motifs immunitaires dans des produits issus d'animaux domestiques
KR102205379B9 (ko) 안정화 아미노산 미네랄 착화합물 및 유산균을 포함하는 면역 활성 증강용 식품, 약학 또는 사료용 조성물
WO2015185945A3 (fr) Polypeptides et leurs utilisations
ITUB20160487A1 (it) Apparato di trattamento di prodotti ortofrutticoli.
MX2022013541A (es) Composiciones de acido gamma-poliglutamico y zinc.
IT201700094800A1 (it) Impianto per la produzione di contenitori, particolarmente contenitori per prodotti medicali, farmaceutici, cosmetici, alimentari o simili

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 15819480

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 2015287622

Country of ref document: AU

Date of ref document: 20150710

Kind code of ref document: A

REEP Request for entry into the european phase

Ref document number: 2015819480

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2015819480

Country of ref document: EP

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 15819480

Country of ref document: EP

Kind code of ref document: A2